Nature of Disclosure: Regulatory filing pursuant to SEBI Listing Regulations, specifically Regulation 29, notifying stock exchanges of an upcoming board meeting.
Key Event: The Board of Directors of Jupiter Life Line Hospitals Limited will meet on Friday, October 23, 2026 to consider, review, and approve the company's financial results.
Financial Results Scope: The board will review and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. The review will include the Limited Review Report for both standalone and consolidated results, as required under Regulation 33 of the SEBI Listing Regulations.
Trading Window Status: The company's trading window for designated persons and their immediate relatives remains closed since September 25, 2026, as previously communicated. The closure will continue for 48 hours after the declaration of the unaudited financial results for the quarter and half year ended September 30, 2026. This is in compliance with the company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015.
Additional Disclosure: Pursuant to Regulation 46(2) of the Listing Regulations, this intimation will be made available on the company's website at www.jupiterhospital.com.